Posted Dec. 11, 2013 at 12:04 p.m.

Premium Lock Oxygen Bio picks DCRI for late-stage clinical trial on heart drug

Published: 2013-12-11 12:04:02
Updated: 2013-12-11 12:04:02

Oxygen Biotherapeutics

Oxygen Biotherapeutics is prepping to start late-stage clinical trials on a drug candidate that could treat low cardiac outpput syndrome and the company is tapping the cardiac surgery trials experience of the Duke Clinical Research Institute to do it....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders